Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3837256 Title: COMPOSÉS URÉIQUES ET COMPOSITIONS UTILISÉS EN TANT QU'INHIBITEURS DE SMARCA2/BRM-ATPASE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
197791452
WO application number:
IB2019056847
Type:
European patent granted for BE
Status:
Open
Publication number:
3837256
WO publication number:
WO2020035779
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
12/08/2019
Grant date:
08/03/2023
EP publication date:
23/06/2021
WO publication date:
20/02/2020
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
08/03/2023
EP B1 publication date:
08/03/2023
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
12/08/2039

Applicant

Name:
Novartis AG
Legal Form:
From:
08/03/2023
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)
To:

Inventor

1

Name:
ADAIR, Christopher
Legal Form:
Address:
Brighton, Massachusetts 02135, United States (US)

2

Name:
PAPILLON, Julien
Legal Form:
Address:
Cambridge, Massachusetts 02139, United States (US)

3

Name:
NAKAJIMA, Katsumasa
Legal Form:
Address:
Cambridge, Massachusetts 02139, United States (US)

4

Name:
SMITH, Troy Douglas
Legal Form:
Address:
Cambridge, Massachusetts 02139, United States (US)

5

Name:
NTAGANDA, Rukundo
Legal Form:
Address:
Cambridge, Massachusetts 02139, United States (US)

Priority

Priority patent number:
201862765138 P
Priority date:
17/08/2018
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07D 417/12; A61P 35/00; A61K 31/4439;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2023/05
Publication date:
29/03/2023
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

1

Issue number:
202310
Publication date:
08/03/2023
Description:
Grant (B1)

2

Issue number:
202317
Publication date:
26/04/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
01/09/2025
Annual fee number:
7
Annual fee amount:
110 Euro
Expected payer:
Last annual fee payment date:
24/07/2024
Last annual fee paid number:
6
Last annual fee paid amount:
95 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type